BIO News
Bio-Rad Laboratories, Inc.
$368.83
-$10.99(-2.89%)
54
Overall
70
Value
50
Tech
44
Quality
Market Cap
$10.16B
Volume
162.23K
52W Range
$236.73 - $396.23
Target Price
$350.60
BIO news: the latest Bio-Rad Laboratories, Inc. headlines, press releases and market updates, newest first.
Latest BIO News
- Crescent Biopharma (CBIO) Gets a Buy from Stifel NicolausTipRanks Auto-Generated Intelligence Newsdesk · Oct 6, 2026
- Analysts’ Top Healthcare Picks: Novartis (NVS), Crescent Biopharma (CBIO)TipRanks Newsroom · Oct 5, 2026
- Biome Australia appoints Moore Australia Audit as new external auditorTipRanks Australian Auto-Generated Newsdesk · Oct 5, 2026
- BioAge Labs initiates Phase 2 trial for BGE-102TipRanks Auto-Generated Newsdesk · Oct 2, 2026
- Analysts Offer Insights on Healthcare Companies: Orchestra BioMed Holdings (OBIO) and Biogen (BIIB)TipRanks Newsroom · Oct 2, 2026
- Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Sagimet Biosciences, Inc. Class A (SGMT) and Jade Biosciences (JBIO)TipRanks Newsroom · Oct 1, 2026
- Orchestra BioMed Completes Enrollment in BACKBEAT AVIM TrialTipRanks Auto-Generated Newsdesk · Oct 1, 2026
- Analysts Offer Insights on Healthcare Companies: AgomAb Therapeutics NV ADR (AGMB) and Jade Biosciences (JBIO)TipRanks Newsroom · Oct 1, 2026
- Analysts Are Bullish on Top Healthcare Stocks: Jade Biosciences (JBIO), Liquidia Technologies (LQDA)TipRanks Newsroom · Sep 30, 2026
- Biotrend Signs Exploratory Biomethane Cooperation MOU With UniperTipRanks Turkey Auto-Generated Newsdesk · Sep 30, 2026
- Biotrend’s Controlling Shareholder Approves TL 1 Billion BIOEN Share PurchaseTipRanks Turkey Auto-Generated Newsdesk · Sep 28, 2026
- Bio-Rad Laboratories (BIO) Receives a Buy from RBC CapitalTipRanks Auto-Generated Intelligence Newsdesk · Sep 28, 2026
- Wall Street Analysts Are Bullish on Top Healthcare PicksTipRanks Newsroom · Sep 25, 2026
- Biome Australia Seeks ASX Quotation for Employee Incentive SharesTipRanks Australian Auto-Generated Newsdesk · Sep 25, 2026
- Xenetic Updates Investors on Santersus Share Exchange PlansTipRanks Auto-Generated Newsdesk · Sep 23, 2026
- Biotrend Reassures Investors Amid Market Volatility and Regulatory ChangesTipRanks Turkey Auto-Generated Newsdesk · Sep 23, 2026
- Valion Bio Names Interim CEO Amid Governance ReshuffleTipRanks Auto-Generated Newsdesk · Sep 23, 2026
- Biome Australia Files Updated Corporate Governance Statement and Appendix 4GTipRanks Australian Auto-Generated Newsdesk · Sep 22, 2026
- Biome Australia Expands Evidence-Based Microbiome Therapeutic PlatformsTipRanks Australian Auto-Generated Newsdesk · Sep 22, 2026
- H.C. Wainwright Keeps Their Buy Rating on Zenas BioPharma, Inc. (ZBIO)TipRanks Auto-Generated Intelligence Newsdesk · Sep 21, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BIO | $368.83 | -2.9% | 162.23K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Bio-Rad Laboratories, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW